| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/30/2002 | US6380216 Use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders |
| 04/30/2002 | US6380215 For prevention and/or treatment of diseases caused by thrombus formation such as arterial thrombosis, arterial sclerosis, ischemic heart diseases |
| 04/30/2002 | US6380214 Thiophene-3-carboxylic acid amide derivatives |
| 04/30/2002 | US6380211 For treating diabetes |
| 04/30/2002 | US6380208 Administering nicergoline, optionally in combination with a pharmaceutically acceptable carrier for therapy of pyramidal spasticity of neurological diseases involving an attack of the pyramidal pathway |
| 04/30/2002 | US6380207 1h-(1)benzopyrano(3,4-f) quinoline derivatives |
| 04/30/2002 | US6380206 Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivatives |
| 04/30/2002 | US6380204 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist activity |
| 04/30/2002 | US6380202 Selective fungicidal activity and high systemicity |
| 04/30/2002 | US6380201 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists |
| 04/30/2002 | US6380200 Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications |
| 04/30/2002 | US6380199 Treatment of attention deficit hyperactivity disorder |
| 04/30/2002 | US6380198 Lowering the intraocular pressure |
| 04/30/2002 | US6380197 For treating and preventing a plethora of diseases including diabetes |
| 04/30/2002 | US6380196 Bronchial therapeutics, bronchial dilators |
| 04/30/2002 | US6380195 Including (methylenedioxyphenyl)cyclopenteno(1,2-b)pyridine derivatives |
| 04/30/2002 | US6380194 For treatment of subjects suffering from hiv infection |
| 04/30/2002 | US6380191 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/30/2002 | US6380190 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thererof |
| 04/30/2002 | US6380186 Psychotherapeutic agents |
| 04/30/2002 | US6380184 For increased production of wool, milk, and meat by treating animals with therapeutically effective amount of compound |
| 04/30/2002 | US6380183 Treatment of diseases involving cyst formation |
| 04/30/2002 | US6380181 Synthetic catechol derivatives, method for production and use thereof |
| 04/30/2002 | US6380179 Administering n-(1-methyl-1-(4-methoxyphenyl)ethyl)-3-oxo-4-aza-5alpha-andro st-1-ene-17beta-carbaxamide |
| 04/30/2002 | US6380178 Cyclic regimens using cyclocarbamate and cyclic amide derivatives |
| 04/30/2002 | US6380177 LPA analogs as agonists of the Edg2 LPA receptor |
| 04/30/2002 | US6380176 Method for inhibiting non-intentional behavior with a running neuron inhibitory substance |
| 04/30/2002 | US6380175 Method for enhancement of delivery of THC by the administration of its prodrugs via the nasal route |
| 04/30/2002 | US6380173 Use of low-molecular-weight heparins for the prevention and treatment of trauma of the central nervous system |
| 04/30/2002 | US6380171 Administering antisense nucleic acid having a nucleotide sequence to suppress expression of pro-protein converting enzyme 5 (pc5) gene or to inhibit pc5 activity for reducing restenosis occuring at injured vascular site |
| 04/30/2002 | US6380170 Nucleic acid construct for the cell cycle regulated expression of structural genes |
| 04/30/2002 | US6380168 Administering 3-o-.beta.-glucopyranosyl(1-6)-.beta.-d-glucopyranosyl indole, 2-s-.beta.-d-glucopyranosyl-3-o-.beta.-d-glucopyranosyl-2-merc aptoindole for increasing blood flow to skin |
| 04/30/2002 | US6380167 Methods for anti-tumor therapy |
| 04/30/2002 | US6380163 Containing osmotic agent with an additional osmotic agent such as dextrose |
| 04/30/2002 | US6380155 Use of vasopressin receptor antagonist for regulation of ACTH release |
| 04/30/2002 | US6379950 Recombinant, active caspases and uses thereof |
| 04/30/2002 | US6379931 Derived from spacer reagent 3-(4,4'-dimethoxytrityloxy)propane-1-((2-cyanoethyl)-(n,n-diisopropyl)) -phosphoramidite; use treating viral and rna-mediated diseases such as hiv |
| 04/30/2002 | US6379927 Retinoblastoma fusion proteins |
| 04/30/2002 | US6379715 Method for treatment of psoriasis |
| 04/30/2002 | US6379707 Solid solution of amorphous pharmaceutically active agent, pharmaceutically acceptable hydrophobic vehicle, stabilizer, disintegrant; shelf life |
| 04/30/2002 | US6379706 Rapidly disintegrating coated pellets with delayed release |
| 04/30/2002 | US6379705 Pellets; controlling concentration |
| 04/30/2002 | US6379704 Method for preparing microparticles having a selected polymer molecular weight |
| 04/30/2002 | US6379702 Flexibility; contour conforming; applying to skins |
| 04/30/2002 | US6379700 An oil-in-water fluid emulsion prepared by phase inversion and comprising an emulsifier is sprayed at room temperature onto a powder, e.g. drugs, to coat; compression to obtain tablets |
| 04/30/2002 | US6379696 Adjust absorption |
| 04/30/2002 | US6379695 Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis dermatitis and dermatosis |
| 04/30/2002 | US6379694 Containing cashew nut sheel oil |
| 04/30/2002 | US6379692 Water insoluble drug ; adjustment of ph with acid |
| 04/30/2002 | US6379685 Acidic aqueous chlorite teat dip with improved emollient providing shelf life, sanitizing capacity and tissue protection |
| 04/30/2002 | US6379684 Cosmetic compositions containing cromolyn compounds for revitalizing the skin |
| 04/30/2002 | US6379678 Culture product; antiallergens |
| 04/30/2002 | US6379675 Immunological combination compositions and methods |
| 04/30/2002 | US6379667 Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction |
| 04/30/2002 | US6379660 Nitric oxide-releasing 1-[(2-carboxylato)pyrrolidin-1-yl] diazen-1-ium-1,2-diolates and composition comprising same |
| 04/30/2002 | US6379651 Administering and ingesting peroral tablets of an antibiotic/antibacterial compound with a bismuth compound, and chewing within oral cavity |
| 04/30/2002 | US6379649 Useful for diagnosis and treatment, including radiotherapy, of disorders that are characterized by an abnormal density of peripheral benzodiazepine receptors; nerve system disporders |
| 04/30/2002 | US6379355 Spine distraction implant and method |
| 04/30/2002 | US6378526 Methods of ophthalmic administration |
| 04/30/2002 | CA2358678A1 Heterocyclic derivatives useful as pharmaceutical agents |
| 04/30/2002 | CA2267503C Methods and compositions for preventing and treating heartburn |
| 04/30/2002 | CA2241827C Novel substituted 4-(1h-benzimidazol-2-yl)¬1,4|diazepanes useful for the treatment of allergic diseases |
| 04/30/2002 | CA2233541C 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use |
| 04/30/2002 | CA2226683C Isolation of clavulanic acid from fermentation broth by ultrafiltration |
| 04/30/2002 | CA2221417C Anhydrous alendronate monosodium salt formulations |
| 04/30/2002 | CA2203663C Cisapride extended release oral compositions |
| 04/30/2002 | CA2200771C New silicated salicylic acid derivatives with desquamative properties |
| 04/30/2002 | CA2196207C Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 04/30/2002 | CA2194976C Wound healing agent |
| 04/30/2002 | CA2177823C Poly-beta-1-->4-n-acetylglucosamine |
| 04/30/2002 | CA2172114C New thiophene compounds, process for preparing the same and pharmaceutical compositions containing them |
| 04/30/2002 | CA2131761C Crystals of pyridonecarboxylic acid derivative |
| 04/30/2002 | CA2088931C Phosphonooxy and carbonate derivatives of taxol |
| 04/30/2002 | CA2062496C Avermectin compounds with a 6,5-spiroketal ring system |
| 04/30/2002 | CA2061197C Salicyloyl carnitine and process for its preparation |
| 04/30/2002 | CA2042937C Treatment of ocular hypertension with a synergistic combination |
| 04/30/2002 | CA2042936C Treatment of ocular hypertension with a synergistic combination for ophthalmic use |
| 04/26/2002 | CA2359877A1 Combination treatment for dementia or cognitive deficits associated with alzheimer's disease and parkinson's disease |
| 04/26/2002 | CA2324631A1 A substance or composition for the treatment of cancer |
| 04/25/2002 | WO2002033121A2 Test for the diagnosis of diabetes and compounds for the treatment thereof |
| 04/25/2002 | WO2002033100A2 Regulation of human adenylate cyclase, type iv |
| 04/25/2002 | WO2002033095A2 Regulation of human serine-threonine protein kinase |
| 04/25/2002 | WO2002033090A2 Pharmaceutical preparations and methods for inhibiting tumors |
| 04/25/2002 | WO2002033074A1 Artificial protein having potentiated immunogenicity of epitope |
| 04/25/2002 | WO2002033050A2 Methods and compositions for promoting the maturation of monocytes |
| 04/25/2002 | WO2002033044A2 Methods of high-throughput screening for internalizing antibodies |
| 04/25/2002 | WO2002032974A2 Polymer and its use for the treatment and/or prevention of hyperphosphoremia |
| 04/25/2002 | WO2002032961A2 Novel polypeptides and nucleic acids encoding same |
| 04/25/2002 | WO2002032960A2 Methods of selecting compounds for modulation of bladder function |
| 04/25/2002 | WO2002032955A1 Human gene critical to fertility |
| 04/25/2002 | WO2002032953A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 04/25/2002 | WO2002032920A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/25/2002 | WO2002032919A2 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance |
| 04/25/2002 | WO2002032918A2 Ketolide antibacterials |
| 04/25/2002 | WO2002032917A1 Macrolides |
| 04/25/2002 | WO2002032915A1 Combinatorial libraries of monosaccharides |
| 04/25/2002 | WO2002032906A1 Pharmaceutical compositions |
| 04/25/2002 | WO2002032905A1 Medicinal compositions, dose and method for treating malaria |
| 04/25/2002 | WO2002032904A1 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents |